← Back to Search

Vagus Nerve Stimulation for Motor Learning Enhancement

N/A
Recruiting
Research Sponsored by VA Pittsburgh Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month post training
Awards & highlights

Study Summary

This trial will test whether electrical current applied to the ear can help people learn new motor tasks.

Who is the study for?
This trial is for individuals who had a stroke at least six months ago and are experiencing motor disorders. It's not suitable for those with vestibular disorders, other neurological issues affecting movement, severe eye diseases in both eyes, or pregnant women.Check my eligibility
What is being tested?
The study tests if Transcutaneous Vagus Nerve Stimulation (tVNS), which involves applying electrical current to the ear, can help improve motor learning after a stroke by activating certain neural pathways.See study design
What are the potential side effects?
Potential side effects of tVNS may include discomfort at the stimulation site on the ear, mild headaches, or temporary changes in skin sensation around the area of application.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month post training
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month post training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Precision grip stability (coefficient of variation or root-mean-square error)
Secondary outcome measures
Force signal composition (Fourier transform)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Transcutaneous Vagus Nerve StimulationExperimental Treatment1 Intervention
Transcutaneous vagus nerve stimulation paired with visuomotor task training
Group II: Transcutaneous Stimulation (Sham)Placebo Group1 Intervention
Transcutaneous stimulation paired with visuomotor task training

Find a Location

Who is running the clinical trial?

VA Pittsburgh Healthcare SystemLead Sponsor
32 Previous Clinical Trials
11,405 Total Patients Enrolled

Media Library

Transcutaneous Vagus Nerve Stimulation Clinical Trial Eligibility Overview. Trial Name: NCT05316519 — N/A
Motor Disorders Research Study Groups: Transcutaneous Vagus Nerve Stimulation, Transcutaneous Stimulation (Sham)
Motor Disorders Clinical Trial 2023: Transcutaneous Vagus Nerve Stimulation Highlights & Side Effects. Trial Name: NCT05316519 — N/A
Transcutaneous Vagus Nerve Stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05316519 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How large is the participant pool for this experiment?

"Affirmative. According to clinicaltrials.gov, this trial is actively seeking new participants. It was initially posted on June 1st 2022 and has been updated as recently as March 30th 2022. The experiment requires 4 individuals from one medical centre to be enrolled in the study."

Answered by AI

Are patients still able to register for this research endeavor?

"Per the information posted on clinicaltrials.gov, this study is actively enrolling patients with a timeline beginning June 1st 2022 and ending March 30th 2022."

Answered by AI

Are geriatric patients eligible for participation in this research trial?

"This clinical trial is enrolling participants whose age falls between 18 and 75."

Answered by AI

Who is qualified to participate in this experiment?

"This research project is looking for 4 participants with motor disorders ranging between 18 and 75 years of age. To qualify, those diagnosed with stroke must have a confirmed diagnosis at least half-a-year prior to being included in the study."

Answered by AI

Who else is applying?

What site did they apply to?
Human Engineering Research Laboratories
What portion of applicants met pre-screening criteria?
Met criteria
~0 spots leftby May 2024